Schonfeld Strategic Advisors’s Bio Green Med Solution Inc BGMS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BGMS Stock Details BGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8	Closed	-$10.1K	–	1924
2023 Q3	$10.1K	Sell	8 -177	-96%	-$310K	﹤0.01%	1578
2023 Q2	$392K	Sell	185 -19	-9%	-$42.4K	﹤0.01%	1305
2023 Q1	$420K	Sell	204 -10	-5%	-$29.8K	﹤0.01%	1237
2022 Q4	$514K	Buy	214 +43	+25%	+$159K	﹤0.01%	1512
2022 Q3	$898K	Buy	171 +28	+20%	+$142K	0.01%	1341
2022 Q2	$556K	Hold	143	–	–	0.01%	1310
2022 Q1	$1.57M	Buy	143 +53	+59%	+$643K	0.01%	817
2021 Q4	$1.25M	Buy	90 +61	+210%	+$979K	0.01%	831
2021 Q3	$548K	Buy	29 +1	+4%	+$19.2K	0.01%	1218
2021 Q2	$607K	Sell	28 -10	-26%	-$248K	0.01%	1100
2021 Q1	$972K	Buy	+38	New	+$1.07M	0.01%	906

Other funds holding BGMS

ACM

Altium Capital Management New York $42M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors's BGMS Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Bio Green Med Solution Inc (BGMS) in Q4 2023, closing a stake of 8 shares — an estimated $10.1K sold.

Schonfeld Strategic Advisors first reported a position in BGMS in Q1 2021 and held it in 11 quarters. The position peaked at $1.57M in Q1 2022. 8 funds tracked by Wall St. Rank hold BGMS as of Q4 2023.

Schonfeld Strategic Advisors reported no remaining Bio Green Med Solution Inc position as of Q4 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 8 Bio Green Med Solution Inc shares in Q4 2023, an estimated $10.1K.
Schonfeld Strategic Advisors first reported a position in Bio Green Med Solution Inc in Q1 2021 and held it in 11 quarters.
Schonfeld Strategic Advisors's Bio Green Med Solution Inc position peaked at $1.57M in Q1 2022.
8 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.